Presentation Overview

Similar documents
Australian Research Centre in Sex, Health & Society. EMBARGOED until am 4/8/09 Secondary Students and Sexual Health 2008

Why Condoms Still Matter. Bidia Deperthes Sr HIV Prevention Advisor- AIDS 2018 Amsterdam

STI Indicators by STI

Ron Gray, MBBS, MFCM, MSc Johns Hopkins University. STIs in an International Setting

THE GROWING NEED FOR FC2 DUAL PROTECTION DISEASE PREVENTION AND CONTRACEPTION IN THE US AND GLOBALLY

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence

Sexual Q & A Game - Birth Control cards - From 5 to 100 Points

STDs and HIV. A review of related clinical and social issues as they apply to Laos Presenter: Ted Doughten M.D.

SEX AND SEXUALLY TRANSMITTED INFECTIONS

For People Who Have Been Sexually Assaulted... What You Need To Know about STDs and Emergency Contraception

Presentation to the Worcester Board of Health Matilde Castiel MD June 9, 2016

SYNDROMIC CASE MANAGEMENT OF STD

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

Family Planning Title X Chlamydia Screening Quality Improvement Project

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

Sexually Transmitted Infections. Naluce Manuela Morris, MPH, CHES

Sexually Transmitted Infections in HSV-2 Seropositive women in Sub- Saharan Africa HPTN 039

FAMILY HIV CENTER NJ CARES SANE

Sexually Transmitted Infections. Kim Dawson October 2010

Buve, A., H. A. Weiss, et al. (2001). The epidemiology of trichomoniasis in women in four African cities. Aids 15 Suppl 4: S89-96.

SEXUALLY TRANSMITTED INFECTIONS (STIs)

9p1 Identify the factors that contribute to positive relationships with others. 9p6 Describe the factors that lead to responsible sexual relationships

Protecting Your Health: Understanding and Preventing STDs

Outline. HIV and Other Sexually Transmitted Infections. Gonorrhea Epidemiology. Epidemiology 11/2/2012

1. Which of the following is an addition to components of reproductive health under the new paradigm

Sexually Transmitted Diseases This publication was made possible by Grant Number TP1AH from the Department of Health and Human Services,

STD Epidemiology. Jonathan Zenilman, MD Johns Hopkins University

The Impact of Sexually Transmitted Diseases(STD) on Women

Additional North Carolina Projects

Contraception for Women and Couples with HIV. Knowledge Test

Several of the most common STDs are often asymptomatic. Asymptomatic

STI vaccines are a major priority for sustainable global STI control. Large number of infections globally

The Synergy between HIV and other STIs

Trends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems

Sexually Transmitted Infections Epidemiology

Sexually Transmitted

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -

ADOLESCENT SEXUALITY - SHS Anonymous Survey Results Heather Johnson

Contraception & HIV Still searching for answers after >2 decades

What You Need to Know. Sexually Transmitted Infections (STIs)

Sexually Transmitted Infection Treatment and HIV Prevention

Family Planning and Sexually Transmitted. Infections, including HIV

Answers to those burning questions -

February 2, Re: Downclassification of female condoms. Dear Dr. Shuren,

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?

STI & HIV PRE-TEST ANSWER KEY

Sexually Transmitted Infections

In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise.

transmission (MTCT) of

Hormonal Contraception and the Risk of HIV Acquisition

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

An evaluation of the STD profiles and safe sex practices of a sample of swingers

Test Your Knowledge: STI Questionnaire and Education

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

STRATEGIES TO REDUCE HIV INFECTION AMONG HBCU COLLEGE STUDENTS

What?! Why?! Emergency Contraception. physical consequences. emotional consequences

Acidform Vaginal Gel Contraception and STI Prevention

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

STIs and BBVs. The facts

A Sexual Health Study with Africans in Frankfurt am Main

Challenges to female condom integration into condom programming

Towards universal access

The Role of Individual and Relationship Factors on Contraceptive Use among At-Risk Young Adults

Sexually Transmitted Infections

Contraception and STIs in women over 40

Target Product Profiles for Drug-Drug and Drug-Device MPT Products. Joe Romano, Ph.D. NWJ Group, LLC Microbicide Trials Network

Substance Abuse Treatment, Integrated Care, & the HIV Care Continuum

STATION ONE: BACTERIAL STI S

Chapter 20: Risks of Adolescent Sexual Activity

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313

GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES

Workshop Summary: Scientific Evidence on Condom Effectiveness. for Sexually Transmitted Disease (STD) Prevention. June 12-13, 2000

SUMMARY BOOKLET ASSESSING THE POTENTIAL OF MPTS IN SOUTH AFRICA, UGANDA AND NIGERIA

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Vaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection

Notes to Teacher continued Contraceptive Considerations

2006 Update. Brunei Darussalam

Female Condom. A Powerful Tool for Protection

SEXUALLY TRANSMITTED INFECTIONS (STIS)

Target Product Profiles for Drug-Drug and Drug-Device MPT Products

PRECONCEPTION COUNSELING

Many Rural Ugandans with Genital Ulcers Fail to Seek Health Treatment or to Inform Their Sexual Partners

Genital Tract Infections in HIV- Infected Pregnant Women in South West London

Overview of Health Curriculum:

Introduction Define sexual health brainstorm STI symptoms group work (quiz) Time Activity Resource 5 min Introduction

Contraceptive Technology and Reproductive Health Series: Barrier Methods Post-test

Sexually Transmi/ed Diseases

Sex Health. Deaf Health Talks, March 17, 2011

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?

Sexual Health reproduction in reference to treatment as/for prevention

Howard Brown Health Center

Acknowledgements Table of Contents Introductory Letter by Jessica Danforth Introduction to the Manual

1. What is your date of birth? Month Day Year

Program to control HIV/AIDS

STD. Are sexually transmitted infections (STIs) different from sexually transmitted diseases (STDs)?

Sexually Transmitted Infections Epidemiology

Presentation to the ARCH Program of the New Jersey HIV Planning Group January 19, 2017 Alexis Roth, PhD, MPH

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)

Pre-exposure Prophylaxis for HIV Prevention

How is it transferred?

Transcription:

Effectiveness of female condoms in the prevention of pregnancy and sexually transmitted infections Bidia Deperthes Technical Advisor Condom Programming United Nations Population Fund Theresa Hatzell Hoke Senior Research Associate Family Health International Presentation Overview Effectiveness of female condom in preventing pregnancy evidence from literature recent findings from WHO multi-site trial Effectiveness of female condom in preventing STI transmission evidence from literature recent findings from trial conducted in Madagascar 1

Female condom effectiveness in preventing pregnancy Measuring female condom contraceptive effectiveness Definitions Perfect use: Effectiveness among women who use the device every time they have sexual intercourse, in accordance with instructions every time Typical use: Effectiveness among women who report occasional incorrect or inconsistent use of the device 2

Bounds et al., 1992 106 women recruited in Great Britain STI free Mean age: 32 years 11 sex acts/month Prior experience with male condoms: 98% Results 7 accidental pregnancies, 4 of which among women reporting inconsistent female condom use Discontinuation rate: 56% at 12 months Typical use 15% (rate at 12 months) Farr et al., 1994 Studied the contraceptive efficacy of the female condom in a multim ulti-center study with STI free US and Latin American women US Lat Am. Mean age 29 26 Sex acts/month 12 12.5 prior experience 97% 69% Discont.. Rate 33% 55% 3

Effectiveness of the Female Condom in Preventing Pregnancy 25 20 6 - Month Pregnancy Rate 15 10 Perfect Use Typical Use 5 0 US Latin America Sources: Farr et al, Am J Public Health 1994 Trussell,, 1998 Conducted in 10 family planning centers in Japan; 195 participants used female condom as their only contraceptive method for 6 months. Mean age: 32 years 5 sex acts/month Prior experience with male condoms: 96% Results Perfect use 1% Typical use 3% 4

12-month Pregnancy Rates of Various Barrier Methods 35% 30% 25% 20% 15% 10% Female Condom Male Condom Cervical Cap Diaphragm 5% 0% Source: Contraceptive Technology 2004. WHO multicentric study preliminary results Key question Is equivalent to in the prevention of pregnancy in women attending FP clinics? Study sites 4 WHO collaborative centres: : China, Panama, Nigeria, South Africa 5

WHO Study- the design Prospective non- randomized trial Typical FP patients (students in SA) choosing either or as their main method of contraception 1 week to try out (training phase) Scheduled monthly follow-up visits ( ( 6 mo) Once every 2 months (> 6 months) Data collection Coital diary card for condom use, frequency of sex acts, etc Emergency contraception request Use of other contraceptive methods Study endpoints pregnancy or EC request China (Chengdu) 316 women (112, 158, 36 MX) Mean age 32 32 prior experience 100% 98% as main meth. 96% 94% Results Sex acts/month 7 6.5 6-mo preg.. Rates % 8.4(8.5) 4.3(4.4) Discont.. Rate % 0.8% 15.4% * 6

Panama 235 women (108, 100, 27 MX) Mean age 27 26 prior experience 58% 55% as main method 25% 29% Results Sex acts/month 6 5 5 4 6-mo preg.. rates 6.2(6.7) 2.4(3.0) Discont.. rates 12% 25% Nigeria (Sagamu( Sagamu) 260 women (62, 157, 41 MX) Mean age 26 28 prior experience 77% 73% as main method 63% 53% Results Sex acts/month 12 11 11 11 9 6-mo preg.. rates 3.6(3.9) 5.9 (5.9) Discont.. rates 25% 22% 7

South Africa (Durban) 260 women (62, 157, 41 MX) Mean age 21 22 prior experience 96% 94% as main method 98% 92% Results Sex acts/month 13 7 12 10 10 6-mo preg.. rates 0(0.7) 0(0.1) Discont.. rates 71% 36% * WHO study- conclusions First contraceptive trial comparing to Few pregnancies leading to low pregnancy rates High level of condom use (>95%) No statistical difference was observed between the pregnancy rates at 6 months. In that respect the two devices are substantially identical in preventing unwanted pregnancy. 8

Female Condom Effectiveness in Preventing Sexually Transmitted Infection Indirect Evidence of STI Protection Offered by the Female Condom Physical properties: polyurethane impermeable to virus particles smaller than HIV, hepatitis B, and herpes virus less prone to breakage more genital coverage Mathematical models: use pregnancy data to project that female condom use reduces HIV transmission 9

Female Condom s Protection against Trichomoniasis, Soper et al., 1993 Assessed whether appropriate use of the female condom decreased the rate of recurrent trichomoniasis. Methods Enrolled 104 US women with recurrent TV Assigned to either a group using the female condom or a control group of non- users Results Re-infection with trichomoniasis occurred in 14% of controls 14.7% of non-perfect users none of the perfect users Female condom s protection against STIs, Fontanet et al., 1998 Assessed whether use of protection was greater and STI prevalence was lower among sex workers having access to female condom. Methods Brothels (N=71) in four cities randomized into two groups: 249 sex workers had access to both and 255 sex workers had access only to Participants returned every 2 weeks for interview, coital log review, and testing for GC, CT, TV, GUD. 10

Female condom s protection against STIs, Fontanet et al., 1998 Results (over 24 weeks) Trial completion rates 27% in + group 24% in group Unprotected sex acts 5.9% for + group 7.1% for only group STI incidence per 100 women per week 2.8 for + group 3.7 for only group. Female condom s s protection against STIs, Feldblum et al., 2000 Measured impact of female condom introduction and education on STI prevalence among female agricultural workers in Kenya. Methods 6 matched pairs of plantations; in each pair, one site randomized to only; the other site to + Total of 160 female employees enrolled per site Clinic- and community based condom distribution and risk-reduction education Participants interviewed, tested for STI at baseline, 6 months, 12 months 11

30 25 20 15 10 5 0 STD Prevalence at Baseline and Follow-up (%) Intervention Control Baseline 6 month 12 month Kenya community intervention trial: process evaluation findings Novelty of male condom promotion Weak encouragement of condom use by clinic-based providers Inconsistent female condom distribution in intervention sites Social opposition to female condom distribution 12

Female condom s protection against STIs, French et al., 2003 Compared STI rates between women given small-group education on, and free samples of, either male or female condoms. Methods 1,442 female STI clinic patients randomized to receive either the male or female condom. Assessed new cases of gonorrhea, chlamydia, trichomoniasis, and primary syphilis by mean of medical records. Results STI incidence per 100 women per month 8.5 for group 6.8 for group Female condom s protection against STIs, University of Alabama at Birmingham, 1997 Compared STI rates and time to first infection among male and female condom users Methods Enrolled 1,159 STI clients Exposed participants to a comprehensive male and female condom promotion intervention Assessed gonorrhea and chlamydia incidence and condom use in 6 monthly follow-up visits Results Consistent and correct use of either device reduced STI risk by 70% STI incidence was lower among consistent users who mixed methods, compared to exclusive male condom users 13

Measuring the Impact of Male and Female Condom Promotion among Sex Workers in Madagascar, 2005 Examined effect of adding the female condom to a male condom distribution system targeting sex workers. Methods Enrolled 1000 sex workers Months 1-6: male condom promotion Months 7-18: male + female condom promotion Measured levels of protection and STI prevalence at baseline, 6, 12, and 18 months Mean proportion of protected sex acts with clients (last 30 days) Level of protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 57% baseline 6 months 12 months 18 months 14

Mean proportion of protected sex acts with clients (last 30 days) Level of protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 57% 78% baseline 6 months 12 months 18 months Mean proportion of protected sex acts with clients (last 30 days) Level of protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 78% 57% 64% baseline 6 months 12 months 18 months 15

Mean proportion of protected sex acts with clients (last 30 days) Level of protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 83% 78% 57% 64% baseline 6 months 12 months 18 months Mean proportion of protected sex acts with clients (last 30 days) Level of protection 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 83% 88% 78% 57% 64% 68% baseline 6 months 12 months 18 months 16

Proportion of participants with any STI (n=818) 70% STI prevalence 60% 50% 40% 30% 20% 53% 49% 41% 40% 10% 0% baseline 6 months 12 months 18 months Proportion of participants reporting use of protection in last sex act with non-paying partner last act protected 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 0 2 4 6 8 10 12 14 16 18 17

Conclusions on female condom effectiveness 1. Female condom is an effective contraceptive 2. Female condom is an effective method for preventing STI transmission 3. Slender evidence that the addition of the female condom to a male condom distribution system targeting high-risk women decreases STI prevalence Priority issues for future research on female condom effectiveness Effectiveness of promoting female condom as a dual protection method Effect of female condom availability on STI prevalence in other populations Effectiveness of female condom in preventing genital ulcerative disease Impact of female condom introduction on HIV transmission 18